Last reviewed · How we verify
Solo 3 group
At a glance
| Generic name | Solo 3 group |
|---|---|
| Sponsor | ANRS, Emerging Infectious Diseases |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Hybrid Group Singing (NA)
- Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach (NA)
- Pelvic Floor Muscle Training vs. Pilates Exercises for Urinary Incontinence (NA)
- Comparative Effects of Vocal and Breathing Exercises on Respiratory Function and Trunk Stability in Women (NA)
- Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial (NA)
- Effects of a 12-Week Waltz Dance Intervention on Cardiovascular Health in Women Aged 45-65 With Dyslipidemia (NA)
- Human-like Robotic Controllers for Enhanced Motor Learning (NA)
- CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Solo 3 group CI brief — competitive landscape report
- Solo 3 group updates RSS · CI watch RSS
- ANRS, Emerging Infectious Diseases portfolio CI